(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 152.03% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Ideaya Biosciences's revenue in 2025 is $7,000,000.On average, 4 Wall Street analysts forecast IDYA's revenue for 2025 to be $1,515,167,960, with the lowest IDYA revenue forecast at $875,819,630, and the highest IDYA revenue forecast at $2,995,303,135. On average, 6 Wall Street analysts forecast IDYA's revenue for 2026 to be $5,324,545,441, with the lowest IDYA revenue forecast at $534,249,974, and the highest IDYA revenue forecast at $15,280,425,085.
In 2027, IDYA is forecast to generate $10,000,721,609 in revenue, with the lowest revenue forecast at $2,058,176,131 and the highest revenue forecast at $18,787,206,883.